\-\ Texto\\:\\ \ \(0\)\
\-\ patient\\ is\\ a\\ well\\-developed\\,\\ well\\-nourished\\ afebrile\\ boy\\.\\ his\\ tympanic\\ membranes\\ are\\ clear\\ and\\ non\\-bulging\\.\\ pupils\\ are\\ equal\\ and\\ reactive\\ to\\ light\\.\\ his\\ extraocular\\ muscles\\ are\\ intact\\ and\\ he\\ has\\ some\\ mild\\ tenderness\\ on\\ the\\ left\\ side\\ of\\ his\\ mandible\\.\\ his\\ oral\\ cavity\\ and\\ pharynx\\ appear\\ moist\\ without\\ gross\\ lesions\\ or\\ exudate\\.\\ pulmonary\\,\\ cardiac\\,\\ and\\ abdominal\\ exams\\ are\\ unremarkable\\.\\ he\\ does\\ not\\ have\\ any\\ rashes\\.\\ his\\ neurological\\ exam\\ is\\ significant\\ for\\ decreased\\ sensation\\ on\\ the\\ left\\ side\\ of\\ his\\ face\\ near\\ the\\ angle\\ of\\ the\\ mandible\\,\\ and\\ facial\\ asymetry\\ with\\ smiling\\.\\ otherwise\\,\\ his\\ neurological\\ exam\\ is\\ unremarkable\\.\ \(0\)\
\-\ initial\\ cbc\\ and\\ cmp\\ were\\ unremarkable\\.\ \(0\)\
\-\ surgical\\ resection\\ of\\ the\\ tumor\\ was\\ not\\ possible\\ due\\ to\\ it\\'s\\ anatomical\\ relationship\\ with\\ vital\\ structures\\.\\ patient\\ had\\ a\\ port\\ placed\\ and\\ underwent\\ radiation\\ and\\ chemotherapy\\ with\\ vincristine\\ and\\ cyclophosphamide\\.\\ the\\ tumor\\ responded\\ well\\ to\\ this\\ regimen\\,\\ and\\ is\\ now\\ quiescent\\.\\ however\\,\\ he\\ did\\ have\\ recurrent\\ sinusitis\\ after\\ treatment\\ and\\ eventually\\ received\\ a\\ bilateral\\ endoscopic\\ sinus\\ procedure\\ with\\ maxillary\\ antrostomy\\.\ \(0\)\
\-\ head\\ ct\\ without\\ contrast\\:\ \(0\)\
\-\ \\â\\€\\¢extensive\\ bony\\ destruction\\ at\\ the\\ skull\\ base\\ involving\\ the\\ left\\ sphenoid\\ bone\\,\\ clivus\\,\\ dorsum\\ sellae\\,\\ tip\\ of\\ the\\ left\\ petrous\\ apex\\,\\ left\\ optic\\ apex\ \(0\)\
\-\ \\â\\€\\¢soft\\ tissue\\ density\\ extending\\ from\\ the\\ sphenoid\\ sinus\\ into\\ the\\ medial\\ aspect\\ of\\ the\\ left\\ middle\\ fossa\ \(0\)\
\-\ brain\\ mri\\,\\ w\\/wo\\ contrast\ \(0\)\
\-\ \\â\\€\\¢infiltrative\\ enhancing\\ nasopharyngeal\\ midline\\ mass\\ that\\ extends\\ into\\ the\\ medial\\ aspect\\ of\\ the\\ left\\ middle\\ cranial\\ fossa\\,\\ sphenoid\\ sinus\\ and\\ anteriorly\\ into\\ the\\ ethmoid\\ air\\ cells\ \(0\)\
\-\ \\â\\€\\¢there\\ is\\ a\\ large\\ central\\ non\\-enhancing\\ portion\\ of\\ the\\ mass\\ suggesting\\ central\\ necrosis\ \(0\)\
\-\ nasopharyngeal\\ embryonal\\ rhabdomyosarcoma\ \(1\)\
\-\ 1\\.\\ rhabdomyosarcoma\\ \ \(0\)\
\-\ 2\\.\\ chondrosarcoma\\ \ \(0\)\
\-\ 3\\.\\ nasopharyngeal\\ sarcoma\\ \ \(0\)\
\-\ 4\\.\\ nasopharyngeal\\ carcinoma\\ \ \(0\)\
\-\ 5\\.\\ craniopharyngioma\ \(0\)\
\-\ previously\\ healthy\\ 6\\ year\\-old\\ male\\ presents\\ with\\ a\\ 3\\ week\\ history\\ of\\ headaches\\.\\ approximately\\ 1\\ week\\ prior\\,\\ he\\ was\\ admitted\\ for\\ observation\\.\\ the\\ ct\\ scan\\ of\\ his\\ head\\ from\\ the\\ outside\\ institution\\ was\\ interpreted\\ as\\ sinusitis\\ and\\ he\\ was\\ discharged\\ on\\ augmentin\\.\\ \\ \\ headaches\\ have\\ persisted\\ since\\ time\\ of\\ discharge\\ and\\ they\\ are\\ now\\ accompanied\\ with\\ emesis\\,\\ drooling\\,\\ left\\-sided\\ facial\\ droop\\,\\ decreased\\ oral\\ intake\\,\\ and\\ blurred\\ vision\\.\ \(0\)\
\-\ this\\ patient\\ was\\ found\\ to\\ have\\ nasopharyngeal\\ embryonal\\ rhabdomyosarcoma\\.\\ the\\ primary\\ site\\,\\ histological\\ subtype\\,\\ and\\ age\\ of\\ diagnosis\\ is\\ consistent\\ with\\ what\\ has\\ been\\ described\\ in\\ the\\ literature\\.\\ he\\ did\\ not\\ have\\ nodal\\ involvement\\,\\ meningeal\\ invasion\\,\\ or\\ distant\\ metastases\\ at\\ diagnosis\\.\\ the\\ anatomical\\ location\\ of\\ his\\ tumor\\ made\\ him\\ a\\ poor\\ surgical\\ candidate\\.\ \(0\)\
\-\ this\\ patient\\ would\\ be\\ considered\\ in\\ clinical\\ group\\ iii\\ with\\ a\\ tnm\\ staging\\ of\\ 2\\ in\\ an\\ unfavorable\\ location\\.\\ based\\ on\\ these\\ parameters\\,\\ his\\ prognosis\\ for\\ event\\-free\\ three\\ year\\ survival\\ is\\ roughly\\ 70\\%\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ his\\:\\ 0\\.30206431232936326\ \(0\)\
\-\ nasopharyngeal\\:\\ 0\\.29997358269541335\ \(0\)\
\-\ the\\:\\ 0\\.2087021593735518\ \(0\)\
\-\ he\\:\\ 0\\.17696144093453237\ \(0\)\
\-\ and\\:\\ 0\\.1749622986121883\ \(0\)\
\-\ rhabdomyosarcoma\\:\\ 0\\.1512072260494415\ \(0\)\
\-\ sphenoid\\:\\ 0\\.15030389913130818\ \(0\)\
\-\ of\\:\\ 0\\.13645671556805467\ \(0\)\
\-\ left\\:\\ 0\\.1359206208483346\ \(0\)\
\-\ have\\:\\ 0\\.12440535093004122\ \(0\)\
\-\ embryonal\\:\\ 0\\.11665311385541505\ \(0\)\
\-\ anatomical\\:\\ 0\\.11088623875306852\ \(0\)\
\-\ sinus\\:\\ 0\\.1079694817162895\ \(0\)\
\-\ mandible\\:\\ 0\\.10532521188623158\ \(0\)\
\-\ sinusitis\\:\\ 0\\.10274710500398802\ \(0\)\
\-\ unremarkable\\:\\ 0\\.10017071335566326\ \(0\)\
\-\ is\\:\\ 0\\.09547890614641012\ \(0\)\
\-\ are\\:\\ 0\\.09449647542741961\ \(0\)\
\-\ apex\\:\\ 0\\.09362252354851582\ \(0\)\
\-\ was\\:\\ 0\\.08679026203709252\ \(0\)\
\-\ facial\\:\\ 0\\.08213841741963022\ \(0\)\
\-\ neurological\\:\\ 0\\.08182564625662149\ \(0\)\
\-\ oral\\:\\ 0\\.07978033419167134\ \(0\)\
\-\ antrostomy\\:\\ 0\\.07965140910344201\ \(0\)\
\-\ sellae\\:\\ 0\\.07965140910344201\ \(0\)\
\-\ into\\:\\ 0\\.07942880673669306\ \(0\)\
\-\ fossa\\:\\ 0\\.07819972520966417\ \(0\)\
\-\ tumor\\:\\ 0\\.07815504095401428\ \(0\)\
\-\ with\\:\\ 0\\.07802185624176614\ \(0\)\
\-\ asymetry\\:\\ 0\\.07611117367923347\ \(0\)\
\-\ headaches\\:\\ 0\\.07430306091353184\ \(0\)\
\-\ smiling\\:\\ 0\\.07359933667171507\ \(0\)\
\-\ quiescent\\:\\ 0\\.07359933667171507\ \(0\)\
\-\ tnm\\:\\ 0\\.07359933667171507\ \(0\)\
\-\ well\\:\\ 0\\.07234963367692682\ \(0\)\
\-\ did\\:\\ 0\\.07145834442866314\ \(0\)\
\-\ middle\\:\\ 0\\.07123155436093247\ \(0\)\
\-\ location\\:\\ 0\\.06936354412050393\ \(0\)\
\-\ side\\:\\ 0\\.06881545779790167\ \(0\)\
\-\ unfavorable\\:\\ 0\\.0687131662053112\ \(0\)\
\-\ now\\:\\ 0\\.06837947590724956\ \(0\)\
\-\ augmentin\\:\\ 0\\.06754726423998814\ \(0\)\
\-\ week\\:\\ 0\\.06700013368391047\ \(0\)\
\-\ central\\:\\ 0\\.06652048183823857\ \(0\)\
\-\ medial\\:\\ 0\\.06484048579310692\ \(0\)\
\-\ patient\\:\\ 0\\.0647981942167411\ \(0\)\
\-\ aspect\\:\\ 0\\.06426411037809895\ \(0\)\
\-\ exudate\\:\\ 0\\.06400702881577958\ \(0\)\
\-\ drooling\\:\\ 0\\.06330815233173985\ \(0\)\
\-\ parameters\\:\\ 0\\.06330815233173985\ \(0\)\
\-\ responded\\:\\ 0\\.06266109377358427\ \(0\)\
\-\ enhancing\\:\\ 0\\.062401578941018686\ \(0\)\
\-\ cyclophosphamide\\:\\ 0\\.0620586966677134\ \(0\)\
\-\ decreased\\:\\ 0\\.06170231605170646\ \(0\)\
\-\ on\\:\\ 0\\.06016965103436001\ \(0\)\
\-\ roughly\\:\\ 0\\.059994716539082664\ \(0\)\
\-\ pharynx\\:\\ 0\\.059546859660195024\ \(0\)\
\-\ rashes\\:\\ 0\\.059546859660195024\ \(0\)\
\-\ droop\\:\\ 0\\.059546859660195024\ \(0\)\
\-\ head\\:\\ 0\\.05941136030288798\ \(0\)\
\-\ not\\:\\ 0\\.058987244062981295\ \(0\)\
\-\ vincristine\\:\\ 0\\.05871467837484273\ \(0\)\
\-\ clivus\\:\\ 0\\.05871467837484273\ \(0\)\
\-\ subtype\\:\\ 0\\.05871467837484273\ \(0\)\
\-\ dorsum\\:\\ 0\\.058326556927707524\ \(0\)\
\-\ persisted\\:\\ 0\\.058326556927707524\ \(0\)\
\-\ blurred\\:\\ 0\\.058326556927707524\ \(0\)\
\-\ nodal\\:\\ 0\\.05759852751212884\ \(0\)\
\-\ tympanic\\:\\ 0\\.05660902134185732\ \(0\)\
\-\ port\\:\\ 0\\.05660902134185732\ \(0\)\
\-\ petrous\\:\\ 0\\.05630262868070397\ \(0\)\
\-\ meningeal\\:\\ 0\\.05600662423598646\ \(0\)\
\-\ cmp\\:\\ 0\\.05544311937653426\ \(0\)\
\-\ moist\\:\\ 0\\.05517444295063417\ \(0\)\
\-\ regimen\\:\\ 0\\.05517444295063417\ \(0\)\
\-\ interpreted\\:\\ 0\\.05517444295063417\ \(0\)\
\-\ histological\\:\\ 0\\.05491378792620257\ \(0\)\
\-\ accompanied\\:\\ 0\\.054414720959844086\ \(0\)\
\-\ intake\\:\\ 0\\.054414720959844086\ \(0\)\
\-\ candidate\\:\\ 0\\.054414720959844086\ \(0\)\
\-\ extraocular\\:\\ 0\\.05417549243667887\ \(0\)\
\-\ relationship\\:\\ 0\\.052863334205984845\ \(0\)\
\-\ without\\:\\ 0\\.05254209432422228\ \(0\)\
\-\ membranes\\:\\ 0\\.052274484495980586\ \(0\)\
\-\ endoscopic\\:\\ 0\\.052086707476352925\ \(0\)\
\-\ ethmoid\\:\\ 0\\.052086707476352925\ \(0\)\
\-\ distant\\:\\ 0\\.052086707476352925\ \(0\)\
\-\ diagnosis\\:\\ 0\\.05163865546578188\ \(0\)\
\-\ this\\:\\ 0\\.051343213425226235\ \(0\)\
\-\ staging\\:\\ 0\\.050874485535635526\ \(0\)\
\-\ exams\\:\\ 0\\.050556948910130385\ \(0\)\
\-\ emesis\\:\\ 0\\.050556948910130385\ \(0\)\
\-\ exam\\:\\ 0\\.050145216834903084\ \(0\)\
\-\ to\\:\\ 0\\.049806091587539854\ \(0\)\
\-\ eventually\\:\\ 0\\.0496682541919863\ \(0\)\
\-\ him\\:\\ 0\\.0495285504934402\ \(0\)\
\-\ pupils\\:\\ 0\\.049391046944807324\ \(0\)\
\-\ maxillary\\:\\ 0\\.049391046944807324\ \(0\)\
\-\ institution\\:\\ 0\\.04925567532021979\ \(0\)\
\-\ literature\\:\\ 0\\.048608616762064204\ \(0\)\
\-\ survival\\:\\ 0\\.048608616762064204\ \(0\)\
\-\ surgical\\:\\ 0\\.04841515078203599\ \(0\)\
\-\ contrast\\:\\ 0\\.04839990626795679\ \(0\)\
\-\ craniopharyngioma\\:\\ 0\\.048123420004951935\ \(0\)\
\-\ what\\:\\ 0\\.04789057167562879\ \(0\)\
\-\ equal\\:\\ 0\\.047663772044077415\ \(0\)\
\-\ group\\:\\ 0\\.047334250111426966\ \(0\)\
\-\ tip\\:\\ 0\\.04681126177425791\ \(0\)\
\-\ observation\\:\\ 0\\.04671032082476848\ \(0\)\
\-\ chondrosarcoma\\:\\ 0\\.04567077844372651\ \(0\)\
\-\ has\\:\\ 0\\.04550030032388333\ \(0\)\
\-\ destruction\\:\\ 0\\.045407503375799074\ \(0\)\
\-\ for\\:\\ 0\\.045287888179234785\ \(0\)\
\-\ anteriorly\\:\\ 0\\.04515193503655903\ \(0\)\
\-\ face\\:\\ 0\\.04490363503737329\ \(0\)\
\-\ suggesting\\:\\ 0\\.04490363503737329\ \(0\)\
\-\ discharge\\:\\ 0\\.04466220136332267\ \(0\)\
\-\ invasion\\:\\ 0\\.04442726445729196\ \(0\)\
\-\ vital\\:\\ 0\\.04435033625142023\ \(0\)\
\-\ gross\\:\\ 0\\.0441984838172501\ \(0\)\
\-\ prognosis\\:\\ 0\\.04383002007797038\ \(0\)\
\-\ angle\\:\\ 0\\.04368688089054096\ \(0\)\
\-\ received\\:\\ 0\\.043338974513080386\ \(0\)\
\-\ light\\:\\ 0\\.04313669608689001\ \(0\)\
\-\ vision\\:\\ 0\\.04313669608689001\ \(0\)\
\-\ afebrile\\:\\ 0\\.043004401209224906\ \(0\)\
\-\ iii\\:\\ 0\\.043004401209224906\ \(0\)\
\-\ optic\\:\\ 0\\.04287408095584241\ \(0\)\
\-\ reactive\\:\\ 0\\.04274567724637021\ \(0\)\
\-\ discharged\\:\\ 0\\.04274567724637021\ \(0\)\
\-\ muscles\\:\\ 0\\.04268217664004508\ \(0\)\
\-\ sensation\\:\\ 0\\.04268217664004508\ \(0\)\
\-\ healthy\\:\\ 0\\.042250151669183916\ \(0\)\
\-\ poor\\:\\ 0\\.042012550752488956\ \(0\)\
\-\ sarcoma\\:\\ 0\\.041781244646058514\ \(0\)\
\-\ cbc\\:\\ 0\\.04155590840089862\ \(0\)\
\-\ cavity\\:\\ 0\\.041121965939114116\ \(0\)\
\-\ 70\\:\\ 0\\.041121965939114116\ \(0\)\
\-\ extends\\:\\ 0\\.04101676834266288\ \(0\)\
\-\ admitted\\:\\ 0\\.04081010082721167\ \(0\)\
\-\ cranial\\:\\ 0\\.040708572998549825\ \(0\)\
\-\ near\\:\\ 0\\.04055846107966191\ \(0\)\
\-\ skull\\:\\ 0\\.040410886385464834\ \(0\)\
\-\ described\\:\\ 0\\.040410886385464834\ \(0\)\
\-\ metastases\\:\\ 0\\.04026576457015515\ \(0\)\
\-\ site\\:\\ 0\\.040170339632526704\ \(0\)\
\-\ previously\\:\\ 0\\.03998256261289906\ \(0\)\
\-\ outside\\:\\ 0\\.03998256261289906\ \(0\)\
\-\ recurrent\\:\\ 0\\.039936242637504706\ \(0\)\
\-\ procedure\\:\\ 0\\.03970825853944072\ \(0\)\
\-\ from\\:\\ 0\\.0395620468862499\ \(0\)\
\-\ appear\\:\\ 0\\.0392267117349564\ \(0\)\
\-\ placed\\:\\ 0\\.03881085719446479\ \(0\)\
\-\ considered\\:\\ 0\\.03881085719446479\ \(0\)\
\-\ made\\:\\ 0\\.03841391180025785\ \(0\)\
\-\ bony\\:\\ 0\\.03837519202556502\ \(0\)\
\-\ cells\\:\\ 0\\.03837519202556502\ \(0\)\
\-\ necrosis\\:\\ 0\\.03807146418814191\ \(0\)\
\-\ mass\\:\\ 0\\.03804949376556889\ \(0\)\
\-\ ct\\:\\ 0\\.03792359134730432\ \(0\)\
\-\ base\\:\\ 0\\.03788686333984225\ \(0\)\
\-\ at\\:\\ 0\\.03762507827022238\ \(0\)\
\-\ midline\\:\\ 0\\.0374591225539929\ \(0\)\
\-\ structures\\:\\ 0\\.03742440562998633\ \(0\)\
\-\ in\\:\\ 0\\.03717070958092346\ \(0\)\
\-\ cardiac\\:\\ 0\\.036985215049462124\ \(0\)\
\-\ clear\\:\\ 0\\.036108219491814704\ \(0\)\
\-\ since\\:\\ 0\\.036078470587791005\ \(0\)\
\-\ based\\:\\ 0\\.036078470587791005\ \(0\)\
\-\ intact\\:\\ 0\\.036048822698916\ \(0\)\
\-\ involvement\\:\\ 0\\.036048822698916\ \(0\)\
\-\ portion\\:\\ 0\\.035615777180466233\ \(0\)\
\-\ they\\:\\ 0\\.03558765704381129\ \(0\)\
\-\ otherwise\\:\\ 0\\.03550383596917168\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.035365897952104694\ \(0\)\
\-\ would\\:\\ 0\\.035257095361843224\ \(0\)\
\-\ involving\\:\\ 0\\.03488662121887162\ \(0\)\
\-\ or\\:\\ 0\\.034653577074301244\ \(0\)\
\-\ does\\:\\ 0\\.03443228951960246\ \(0\)\
\-\ underwent\\:\\ 0\\.034310171516597085\ \(0\)\
\-\ boy\\:\\ 0\\.03407094299343188\ \(0\)\
\-\ extending\\:\\ 0\\.03376943406218176\ \(0\)\
\-\ possible\\:\\ 0\\.03374666665714488\ \(0\)\
\-\ three\\:\\ 0\\.033434003766002605\ \(0\)\
\-\ initial\\:\\ 0\\.033412093353289415\ \(0\)\
\-\ density\\:\\ 0\\.03302682666991492\ \(0\)\
\-\ radiation\\:\\ 0\\.03300591337875644\ \(0\)\
\-\ air\\:\\ 0\\.032577922935935276\ \(0\)\
\-\ found\\:\\ 0\\.03222706477597098\ \(0\)\
\-\ any\\:\\ 0\\.03218893679012302\ \(0\)\
\-\ resection\\:\\ 0\\.03192660347738556\ \(0\)\
\-\ approximately\\:\\ 0\\.03178016323324976\ \(0\)\
\-\ clinical\\:\\ 0\\.03156500750346453\ \(0\)\
\-\ some\\:\\ 0\\.03133775376738129\ \(0\)\
\-\ age\\:\\ 0\\.03126900305874701\ \(0\)\
\-\ tenderness\\:\\ 0\\.031234829649626504\ \(0\)\
\-\ brain\\:\\ 0\\.031049229919786377\ \(0\)\
\-\ year\\:\\ 0\\.03069875486458524\ \(0\)\
\-\ primary\\:\\ 0\\.03062561388281999\ \(0\)\
\-\ pulmonary\\:\\ 0\\.030359347486161606\ \(0\)\
\-\ carcinoma\\:\\ 0\\.02979198689916415\ \(0\)\
\-\ scan\\:\\ 0\\.029549633359901024\ \(0\)\
\-\ time\\:\\ 0\\.02952155843254696\ \(0\)\
\-\ however\\:\\ 0\\.02947961458142437\ \(0\)\
\-\ been\\:\\ 0\\.029017821075660234\ \(0\)\
\-\ significant\\:\\ 0\\.028757166051228633\ \(0\)\
\-\ due\\:\\ 0\\.02862969962852503\ \(0\)\
\-\ lesions\\:\\ 0\\.028604428135095943\ \(0\)\
\-\ mild\\:\\ 0\\.028233879111269438\ \(0\)\
\-\ these\\:\\ 0\\.028125713028745402\ \(0\)\
\-\ prior\\:\\ 0\\.027866814698057404\ \(0\)\
\-\ abdominal\\:\\ 0\\.027240486703998017\ \(0\)\
\-\ bone\\:\\ 0\\.0271759694531714\ \(0\)\
\-\ consistent\\:\\ 0\\.027006218397946744\ \(0\)\
\-\ bilateral\\:\\ 0\\.026767841833106293\ \(0\)\
\-\ tissue\\:\\ 0\\.026127358320566122\ \(0\)\
\-\ were\\:\\ 0\\.02567380278278956\ \(0\)\
\-\ mri\\:\\ 0\\.025566229000479508\ \(0\)\
\-\ it\\:\\ 0\\.02549524247219968\ \(0\)\
\-\ large\\:\\ 0\\.024955520332929745\ \(0\)\
\-\ had\\:\\ 0\\.02481542104301534\ \(0\)\
\-\ after\\:\\ 0\\.024161941341750506\ \(0\)\
\-\ presents\\:\\ 0\\.0239594891959\ \(0\)\
\-\ treatment\\:\\ 0\\.02372547063472338\ \(0\)\
\-\ male\\:\\ 0\\.02217576216917001\ \(0\)\
\-\ that\\:\\ 0\\.021614145769741248\ \(0\)\
\-\ be\\:\\ 0\\.02020449896876333\ \(0\)\
\-\ as\\:\\ 0\\.02000903184281531\ \(0\)\
\-\ an\\:\\ 0\\.019045831884299765\ \(0\)\
\-\ history\\:\\ 0\\.019028959811640298\ \(0\)\
